642 related articles for article (PubMed ID: 28841802)
1. Advanced magnetic resonance imaging in glioblastoma: a review.
Shukla G; Alexander GS; Bakas S; Nikam R; Talekar K; Palmer JD; Shi W
Chin Clin Oncol; 2017 Aug; 6(4):40. PubMed ID: 28841802
[TBL] [Abstract][Full Text] [Related]
2. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
[TBL] [Abstract][Full Text] [Related]
3. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
4. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
5. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
6. Diffusion tensor magnetic resonance imaging driven growth modeling for radiotherapy target definition in glioblastoma.
Jensen MB; Guldberg TL; Harbøll A; Lukacova S; Kallehauge JF
Acta Oncol; 2017 Nov; 56(11):1639-1643. PubMed ID: 28893125
[TBL] [Abstract][Full Text] [Related]
7. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
8. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
[TBL] [Abstract][Full Text] [Related]
9. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
[TBL] [Abstract][Full Text] [Related]
10. Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.
Gonçalves FG; Chawla S; Mohan S
J Magn Reson Imaging; 2020 Oct; 52(4):978-997. PubMed ID: 32190946
[TBL] [Abstract][Full Text] [Related]
11. Findings of DTI-p maps in comparison with T
Beigi M; Safari M; Ameri A; Moghadam MS; Arbabi A; Tabatabaeefar M; SalighehRad H
Cancer Imaging; 2018 Sep; 18(1):33. PubMed ID: 30227891
[TBL] [Abstract][Full Text] [Related]
12. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Jayachandran Preetha C; Meredig H; Brugnara G; Mahmutoglu MA; Foltyn M; Isensee F; Kessler T; Pflüger I; Schell M; Neuberger U; Petersen J; Wick A; Heiland S; Debus J; Platten M; Idbaih A; Brandes AA; Winkler F; van den Bent MJ; Nabors B; Stupp R; Maier-Hein KH; Gorlia T; Tonn JC; Weller M; Wick W; Bendszus M; Vollmuth P
Lancet Digit Health; 2021 Dec; 3(12):e784-e794. PubMed ID: 34688602
[TBL] [Abstract][Full Text] [Related]
13. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.
Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044
[TBL] [Abstract][Full Text] [Related]
14. The effect of glioblastoma heterogeneity on survival stratification: a multimodal MR imaging texture analysis.
Liu Y; Zhang X; Feng N; Yin L; He Y; Xu X; Lu H
Acta Radiol; 2018 Oct; 59(10):1239-1246. PubMed ID: 29430935
[TBL] [Abstract][Full Text] [Related]
15. Brain metastases from breast cancer using magnetic resonance imaging: A systematic review.
Mohammadi M; Mohammadi S; Hadizadeh H; Olfati M; Moradi F; Tanzifi G; Ghaderi S
J Med Radiat Sci; 2024 Mar; 71(1):133-141. PubMed ID: 37563948
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
17. Taming Glioblastoma in "Real Time": Integrating Multimodal Advanced Neuroimaging/AI Tools Towards Creating a Robust and Therapy Agnostic Model for Response Assessment in Neuro-Oncology.
de Godoy LL; Chawla S; Brem S; Mohan S
Clin Cancer Res; 2023 Jul; 29(14):2588-2592. PubMed ID: 37227179
[TBL] [Abstract][Full Text] [Related]
18. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
19. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
[TBL] [Abstract][Full Text] [Related]
20. The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies.
Ly KI; Gerstner ER
Curr Treat Options Oncol; 2018 Jun; 19(8):40. PubMed ID: 29931476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]